In a follow-up study, the effect of SI113 was also evaluated in glioblastoma multiforme (GBM), one of the most aggressive brain tumors, given that SGK1 overexpression has been documented in GBM (Talarico et al., 2016). Here, SGK1 is linked to glioblastoma.